PGP and neoplasm: Fluoxetine inhibits tumor multidrug resistance by regulating the expressions of P-glycoprotein (P-gp), ABCB1 (MRP1), and glutathione S-transferase-pi (GST-π), which sensitizes tumors to chemotherapy [34–36].